Skip to main content
OpenTrials
Completed

NCT Number: NCT02221518

Control and Reward Circuits in Obsessive Compulsive Disorder

The purpose of this study is to examine the brain functioning of OCD patients and healthy controls before and after treatment with Exposure and Response Prevention (EXRP) therapy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

NY State Psychiatric Institute

New York, 10032, United States

About this study

The capacity to coordinate thoughts and actions to execute goal-directed behaviors (cognitive control) and the capacity to anticipate, respond to, and learn from reward (reward processing) are key processes for human behavior. Dysfunction in these processes has been hypothesized to contribute to repetitive thoughts and behaviors in many disorders, including obsessive-compulsive disorder (OCD), Tourette Syndrome (TS), and eating disorders. We will use multimodal imaging to investigate neural circuits that support cognitive control and reward processing, using OCD as a model system. The short-term goal is to clarify how circuit-based abnormalities contribute to repetitive thoughts/behaviors; these data will inform future transdiagnostic studies. The long-term goal is to identify control and reward circuit-abnormalities as targets for new transdiagnostic treatments.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for Patients:

  • Male and females with OCD aged 18-55
  • Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Diagnosis of OCD
  • Not on psychotropic medication

Exclusion criteria

for Patients:

  • Presence of metallic devices or dental braces in the body that are contraindicators for MR imaging
  • Comorbid psychiatric conditions that significantly elevate the risk of study participation (e.g. psychotic disorders, bipolar disorder, evidence of dementia or other cognitive disorder, suicidality)
  • Unstable medical conditions that need attention and would make participation in the study unsafe (e.g. very high blood pressure)
  • Use of psychotropic medication
  • Females who are pregnant or post-menopausal

Inclusion criteria

for Healthy Volunteers

  • Male and females aged 18-55

Exclusion criteria

for Healthy Volunteers

  • Presence of metallic devices or dental braces in the body that are contraindicators for MR imaging
  • Any psychiatric diagnosis
  • Use of psychotropic medication
  • Diagnosis of OCD in a first degree relative
  • Females who are pregnant or post-menopausal
  • Unstable medical conditions that need attention and would make participation in the study unsafe (e.g. very high blood pressure)

Treatment and study plan

Exposure & Response Prevention (EX/RP)

Behavioral

Exposure and Response Prevention (EX/RP) is a type of Cognitive Behavioral Treatment for treating OCD.

Primary outcomes

  1. Change from baseline in brain activation (fMRI) and fractional anisotropy (Diffusion tensor imaging) after therapy

    Time frame: Baseline & approximately 10 weeks later

Secondary outcomes

  1. Change in reaction times and correct responses on Stop signal reaction time task

    Time frame: Baseline and approximately 10 weeks later, at second scan

Sponsors and collaborators

Lead sponsor

New York State Psychiatric Institute

Other

Registry information

Official study title

Control & Reward Circuits as Targets for Repetitive Thoughts and Behaviors

Important dates

Study start
2014
Primary completion
2018
Study completion
2018
First posted
Aug 20, 2014
Registry last updated
Mar 13, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.